2012-01-15 TSC WGM SDO Activities Minutes

From HL7 TSC
Revision as of 13:10, 21 December 2011 by Llaakso (talk | contribs)
Jump to navigation Jump to search

TSC Sunday Q4 Agenda - 2012 Jan WGM San Antonio, TX USA

back to TSC Minutes and Agendas
to JIC Projects page

to ISO_and_JIC_projects wiki page

TSC HL7 activities with other SDOs Meeting

Location: TBD

Date: 2012-01-15
Time: Sunday Q4
Facilitator Austin Kreisler Note taker(s) Lynn Laakso
Opportunity for HL7 WGM attendees to review activities in collaboration with other SDOs such as IHE, OMG, and the JWG and JIC, and provide comment.
Attendees:

Agenda

Welcome and Introduction - Austin Kreisler

HL7 Executive Report on Activities with other SDO's

SDO liaison activities and review of each JIC-sponsored event having HL7 engagement (25 mins)

Attached reports:

  • HL7 activities with AHIP: Maria Ward
  • HL7 activities with ADA: Pat Van Dyke
  • HL7 activities with CDISC: Becky Kush
  • HL7 activities with CLSI:
  • HL7 activities with CEN TC 251: Mark Shafarman
  • HL7 activities with DICOM: Helmut Koenig
    • Radiology/Surgery/Pathology Orders Workflow (In cooperation with HL7 Anatomic Pathology WG + HL7 Orders and Observations WG)
      Develop an implementation guide for anatomic pathology orders that better captures data from the surgical or interventional radiology procedure that produced the specimen. In this project we will work on an HL7 v2.x Implementation Guide for pathology orders, including appropriate references to diagnostic and to peri-operative imaging - both biopsy guidance imaging (X-ray, ultrasound, MR) and photographic imaging (e.g., of specimen as excised). Particular consideration will be given to the operational issues in multi-department coordination.
    • Discussion on communication of contrast agent information and associated adverse events
      HL7 II WG / DICOM WG20 started a discussion on how to access and communicate relevant clinical information before and after contrast administration. Contrast agents used to improve medical imaging are not completely devoid of risk. In order to minimize the risks that are associated with the use of contrast media, the group will explore how they can be mitigated by exchanging relevant information between imaging and clinical information systems. Adverse events (contrast reaction, device failure) should be documented in imaging reports. We will evaluate the need for new structured document templates.
    • Cooperation with HL7 Structured Documents WG
      HL7 II WG / DICOM WG20 will continue the discussion on the development of CDA Imaging Report Templates and other harmonization topics.
  • HL7 activities with DSMO: Maria Ward or Mary Lynn Bushman
  • HL7 activities with GS1: Chuck Jaffe
  • HL7 activities with IEEE (11073): Todd Cooper
  • HL7 activities with IHE: Chuck Jaffe, Keith Boone
  • HL7 activities with IHTSDO: Bob Dolin or Russ Hamm
  • HL7 Activities with NCPDP: Margaret Weiker
    • NCPDP WG2 – Product Identification has a task group, The Structure Product Labeling Activities Task Group tracks the activities of the SPL, offers suggestions to improve access and usability of the FDA Structured Product Label and Electronic Drug Listings, and monitors the work of the Guiding Coalition for feedback to the WG. This task group met during the WG meeting. The Coalition has sent seven letters to the FDA and is working on letters regarding Marketing Categories, Inner/Outer NDCs and Identifiers, and Freeness. Two letters, SPL Validation Dates and Fee Definition Update, were reviewed and approved at this meeting. They continue to collaborate with the HL7 SPL Leadership Team/SPL Working Group regarding issues with “Last Marketing Date/Marketing End Date”, “June/December Updates of the SPL” and the “SPL Validation Process”. They are also investigating the process whereby the Billing Unit Standard can be added to the SPL Indexing Files.
    • NCPDP WG11 – ePrescribing and Related Transaction has a task group, NCPDP/HL7 Pharmacist Functional Profile Task Group will discuss analyzing the functional profiles for NIST testing for meaningful use in the future.
    • NCPDP WG14 - Long Term and Post Acute Care (LTPAC) has 1 task groups that interfaces with HL7
      • Automation in LTPAC Task Group – This task group reported they are in the process of creating a white paper on the use of the HL7 messages in pharmacy.
  • HL7 activities with NQF: Chuck Jaffe
  • HL7 activities with NUCC: Maria Ward or Nancy Wilson-Ramon
  • HL7 activities with OMG: Ken Rubin
  • HL7 activities with Regenstrief/LOINC: Ted Klein
  • HL7 activities with SCO: John Quinn or Chuck Jaffe
  • Hl7 Activities with The Health Story Project: Joy Kuhl
  • HL7 Activities with TIGER: Pat Van Dyke
  • HL7 activities with W3C: John Quinn
  • HL7 Activities with WEDI: Maria Ward
  • HL7 Activities with X12: Maria Ward


Panel discussion: (1 hour)

Streamlining current cross SDO processes - SDO perspective

  • Panelists:

Comment period

Minutes